These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 20350588)
21. Metabotropic glutamate receptor modulation of dopamine release in the nucleus accumbens shell is unaffected by phencyclidine pretreatment: In vitro assessment using fast-scan cyclic voltammetry rat brain slices. Gupta I; Young AMJ Brain Res; 2018 May; 1687():155-161. PubMed ID: 29524437 [TBL] [Abstract][Full Text] [Related]
22. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia. Profaci CP; Krolikowski KA; Olszewski RT; Neale JH Psychopharmacology (Berl); 2011 Jul; 216(2):235-43. PubMed ID: 21327758 [TBL] [Abstract][Full Text] [Related]
23. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. Cartmell J; Monn JA; Schoepp DD J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900 [TBL] [Abstract][Full Text] [Related]
24. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Klamer D; Zhang J; Engel JA; Svensson L Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002 [TBL] [Abstract][Full Text] [Related]
26. The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity. Woolley ML; Pemberton DJ; Bate S; Corti C; Jones DN Psychopharmacology (Berl); 2008 Feb; 196(3):431-40. PubMed ID: 18057917 [TBL] [Abstract][Full Text] [Related]
27. Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine. Matsuura A; Fujita Y; Iyo M; Hashimoto K Acta Neuropsychiatr; 2015 Jun; 27(3):159-67. PubMed ID: 25648314 [TBL] [Abstract][Full Text] [Related]
29. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats. Abekawa T; Honda M; Ito K; Koyama T Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123 [TBL] [Abstract][Full Text] [Related]
30. Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture. Ahnaou A; Dautzenberg FM; Geys H; Imogai H; Gibelin A; Moechars D; Steckler T; Drinkenburg WH Eur J Pharmacol; 2009 Jan; 603(1-3):62-72. PubMed ID: 19046965 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat. Gozzi A; Herdon H; Schwarz A; Bertani S; Crestan V; Turrini G; Bifone A Psychopharmacology (Berl); 2008 Dec; 201(2):273-84. PubMed ID: 18704372 [TBL] [Abstract][Full Text] [Related]
32. Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function. Benneyworth MA; Basu AC; Coyle JT Psychopharmacology (Berl); 2011 Jan; 213(1):143-53. PubMed ID: 20865248 [TBL] [Abstract][Full Text] [Related]
34. Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats. Clark M; Johnson BG; Wright RA; Monn JA; Schoepp DD Pharmacol Biochem Behav; 2002 Sep; 73(2):339-46. PubMed ID: 12117588 [TBL] [Abstract][Full Text] [Related]
35. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments. Castañé A; Santana N; Artigas F Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167 [TBL] [Abstract][Full Text] [Related]
36. The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex. Li Z; Boules M; Williams K; Peris J; Richelson E Brain Res; 2010 Jan; 1311():28-36. PubMed ID: 19948149 [TBL] [Abstract][Full Text] [Related]
37. Effects of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats. Gotoh L; Kawanami N; Nakahara T; Hondo H; Motomura K; Ohta E; Kanchiku I; Kuroki T; Hirano M; Uchimura H Brain Res Mol Brain Res; 2002 Apr; 100(1-2):1-12. PubMed ID: 12008016 [TBL] [Abstract][Full Text] [Related]
39. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). Fell MJ; Svensson KA; Johnson BG; Schoepp DD J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR. Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]